Dr John Solomon | Head of Pharmacovigilance
Sanofi-Aventis UK

Dr John Solomon, Head of Pharmacovigilance, Sanofi-Aventis UK

John Solomon is the Head of Pharmacovigilance for UK & Ireland responsible for leading the post authorisation drug surveillance activities for the broad Sanofi portfolio including Innovative, Generics, Biologics and Vaccines products.
Prior to joining Sanofi in 2005, John was the Head of Drug Safety Europe at MDS Pharma Services.
Qualified in medicine, John has worked for over 16 years in the industry spending most of these
years in clinical drug safety and post marketing drug surveillance activities.
Other industry related experience includes pharmaceutical marketing and global
clinical research programmes from within the Pharmaceutical industry and Clinical Research Organisation sector respectively.
John is currently a pharmacovigilance representative on UK Pharmaceutical and Self-care industry trade associations.
John is especially committed to transparency around patient centric pharmacovigilance and the
commercial value of effective Pharmacovigilance.


World Drug Safety Europe Day Two (Wednesday 13 September ) @ 12:05


Master Drug Safety EU
Monika Manske, Associate Director of Global Pharmacovigilance Governance, Mylan Pharmaceuticals Ltd
Andrew Cochrane, Global Head Clinical Risk and Compliance, Novartis
Ian Wong, Head of Research Department of Practice and Policy, University College London
Silvia Stoetter, Global PV Manager, Allergy Therapeutics
Sunayana Shah, Head of regulatory and safety policy, Association of the British Pharmaceutical Industry
Andrea Maulwurf, Head of Pharmacovigilance, EU-QPPV, Allergy Therapeutics
Romualdo Beningni, Consultant, alpha-pretox
Ainhoa Alzualde Zuloaga, Head of Neurotoxicity Area, Biobide- BBD BioPhenix S.L.
Jayne Lawrence, Head of Division of Pharmacy and Optometry, Royal Pharmaceutical Society of GB
Michael Von Forstner, Co-chair, Pharmacovigilance Working Group, Medicines for Europe

back to speakers